StarQuest

Investment leadership sits with Founding Partners Arnaud Delattre (CEO) and Emmanuel Gaudé (Managing Director). The firm lists Harold Dumeurger as Partner and names investment directors Chloé Cohen-Aknine and Quentin Simon as senior deal professionals, indicating a centralized investment committee structure under the founders.

StarQuest operates as a dedicated private equity subsidiary within Montefiore, a platform with €5B in consolidated assets. The relationship gives StarQuest access to Montefiore's broader institutional infrastructure while StarQuest itself retains operational independence in sourcing, investment decisions, and fund management. Regulatory and compliance separation is not publicly detailed.

The three funds cover distinct stage bands. The CCR-Fund invests from seed to LBO with cheques of €500K to €5M, giving it the earliest-stage flexibility. The Biodiversity fund spans venture, growth, and buyout stages with €3M to €15M tickets. The Protect fund concentrates on Series A, B, and C companies poised for fast commercial scaling, deploying €3M to €20M per investment.

The CCR-Fund exclusively targets adaptation and natural-disaster prevention — flood protection, drought-resilient infrastructure, and AI-driven risk modeling — while the Protect fund focuses on emissions reduction technologies across energy, mobility, agriculture, and materials. The Biodiversity fund sits apart, investing in nature-based solutions such as regenerative agriculture, ecosystem restoration, and MRV platforms. The three mandates rarely overlap in portfolio construction.

StarQuest does not publicly disclose LP co-investment programs or club-deal relationships. Its portfolio page lists portfolio companies thematically without naming co-investors or syndicate partners. The investor base behind each fund vehicle remains unpublicized, though Montefiore's parent-level relationships may account for some capital.

While StarQuest is headquartered in Paris, its portfolio shows reach across Europe and into broader international markets. Portfolio highlights include ultralight solar and hydrogen-mobility technologies applicable to multiple geographies, as well as landfill biogas and aquaponic systems deployed internationally. The firm does not restrict itself to France-only deployment, though explicit geographic allocations per fund are not disclosed.

No philanthropic foundations, donor-advised funds, or charitable vehicles tied to StarQuest are publicly disclosed. The firm's biodiversity and climate-adaptation funds are commercial private equity vehicles, not grant-making entities. Impact measurement is integrated into the investment thesis through MRV solutions rather than separated into a non-profit arm.